Related Experiment Video
Updated: Apr 13, 2026

12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
15.4K
Effects of the I682F mutation on JAK2's activity, structure and stability
1Department of Biology, Xuzhou Medical College, No. 209 Tongshan Road, Xuzhou 221002, People's Republic of China.
Summary
The JAK2 I682F mutation increases Janus kinase 2 activity and impairs its structure, potentially causing constitutive activation. This finding offers insights into the mechanism behind JAK2 mutations in B-cell acute lymphoblastic leukemia (B-ALL).
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Janus kinase 2 (JAK2) is crucial for cellular processes like migration and proliferation.
- The JAK2 I682F mutation is found in 4-8% of B-cell acute lymphoblastic leukemia (B-ALL) cases.
- The specific role of the JAK2 I682F mutation in B-ALL development remains unclear.
Purpose of the Study:
- To investigate the mechanism by which the JAK2 I682F mutation contributes to B-ALL.
- To analyze the impact of various JAK2 mutations on enzyme activity and structural stability.
Main Methods:
- Construction and analysis of a series of JAK2 mutations (I682F, I682G, I682D, I682S, I682L).
- Assessment of JAK2 activity and structural stability.
- Spectroscopic experiments to evaluate the structural integrity of the JAK2 JH2 domain.
Main Results:
- Mutations I682F, I682G, I682D, and I682S significantly enhanced JAK2 activity and reduced structural stability.
- The I682L mutation showed minimal impact on JAK2 activity and stability.
- Spectroscopic data indicated that these mutations destabilized the JAK2 JH2 domain, leading to a partially unfolded state.
Conclusions:
- The partially unfolded state of JAK2, induced by mutations like I682F, may lead to its constitutive activation.
- This study provides a mechanistic understanding of how JAK2 I682F mutations contribute to B-ALL pathogenesis.
Related Concept Videos
The JAK-STAT Signaling Pathway
14.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
14.1K
Mutations
45.8K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.8K
Mutations
14.1K
14.1K
Mutations
98.2K
Overview
98.2K
Spontaneous and Induced Mutations
3.3K
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
3.3K
Point and Frameshift Mutations
1.7K
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
1.7K

